192 related articles for article (PubMed ID: 18787417)
1. Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death.
Shekhar MP; Tait L; Pauley RJ; Wu GS; Santner SJ; Nangia-Makker P; Shekhar V; Nassar H; Visscher DW; Heppner GH; Miller FR
Cancer Biol Ther; 2008 Nov; 7(11):1774-82. PubMed ID: 18787417
[TBL] [Abstract][Full Text] [Related]
2. Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.
Khurana A; McKean H; Kim H; Kim SH; mcguire J; Roberts LR; Goetz MP; Shridhar V
Breast Cancer Res; 2012 Mar; 14(2):R43. PubMed ID: 22410125
[TBL] [Abstract][Full Text] [Related]
3. Comedo-DCIS is a precursor lesion for basal-like breast carcinoma: identification of a novel p63/Her2/neu expressing subgroup.
Shekhar MP; Kato I; Nangia-Makker P; Tait L
Oncotarget; 2013 Feb; 4(2):231-41. PubMed ID: 23548208
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome c1 in ductal carcinoma in situ of breast associated with proliferation and comedo necrosis.
Chishiki M; Takagi K; Sato A; Miki Y; Yamamoto Y; Ebata A; Shibahara Y; Watanabe M; Ishida T; Sasano H; Suzuki T
Cancer Sci; 2017 Jul; 108(7):1510-1519. PubMed ID: 28394473
[TBL] [Abstract][Full Text] [Related]
5. IL-6-mediated cross-talk between human preadipocytes and ductal carcinoma in situ in breast cancer progression.
Kim HS; Jung M; Choi SK; Woo J; Piao YJ; Hwang EH; Kim H; Kim SJ; Moon WK
J Exp Clin Cancer Res; 2018 Aug; 37(1):200. PubMed ID: 30134951
[TBL] [Abstract][Full Text] [Related]
6. Dynamic stromal-epithelial interactions during progression of MCF10DCIS.com xenografts.
Tait LR; Pauley RJ; Santner SJ; Heppner GH; Heng HH; Rak JW; Miller FR
Int J Cancer; 2007 May; 120(10):2127-34. PubMed ID: 17266026
[TBL] [Abstract][Full Text] [Related]
7. Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.
Russell TD; Jindal S; Agunbiade S; Gao D; Troxell M; Borges VF; Schedin P
Am J Pathol; 2015 Nov; 185(11):3076-89. PubMed ID: 26343330
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructure of the periductal area of comedo carcinoma in situ of the breast.
Tang P; Teichberg S; Roberts B; Hajdu SI
Ann Clin Lab Sci; 2001 Jul; 31(3):284-90. PubMed ID: 11508833
[TBL] [Abstract][Full Text] [Related]
9. Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells.
Katdare M; Osborne M; Telang NT
Int J Oncol; 2002 Oct; 21(4):809-15. PubMed ID: 12239620
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analog.
Wahler J; So JY; Kim YC; Liu F; Maehr H; Uskokovic M; Suh N
Cancer Prev Res (Phila); 2014 Jun; 7(6):617-26. PubMed ID: 24691501
[TBL] [Abstract][Full Text] [Related]
11. Detection of amplified int-2/FGF-3 gene in primary breast carcinomas using differential polymerase chain reaction.
Naidu R; Wahab NA; Yadav M; Kutty MK; Nair S
Int J Mol Med; 2001 Aug; 8(2):193-8. PubMed ID: 11445874
[TBL] [Abstract][Full Text] [Related]
12. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.
O'Malley FP; Vnencak-Jones CL; Dupont WD; Parl F; Manning S; Page DL
Lab Invest; 1994 Jul; 71(1):67-72. PubMed ID: 8041120
[TBL] [Abstract][Full Text] [Related]
13. Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrence.
Allen MD; Thomas GJ; Clark S; Dawoud MM; Vallath S; Payne SJ; Gomm JJ; Dreger SA; Dickinson S; Edwards DR; Pennington CJ; Sestak I; Cuzick J; Marshall JF; Hart IR; Jones JL
Clin Cancer Res; 2014 Jan; 20(2):344-57. PubMed ID: 24150233
[TBL] [Abstract][Full Text] [Related]
14. Tenascin patterns of expression in duct carcinoma in situ of the breast.
Iskaros BE; Sison CP; Hajdu SI
Ann Clin Lab Sci; 2000 Jul; 30(3):266-71. PubMed ID: 10945566
[TBL] [Abstract][Full Text] [Related]
15. Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s).
Scribner KC; Behbod F; Porter WW
Oncogene; 2013 May; 32(21):2631-9. PubMed ID: 22777354
[TBL] [Abstract][Full Text] [Related]
16. An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ.
Behbod F; Kittrell FS; LaMarca H; Edwards D; Kerbawy S; Heestand JC; Young E; Mukhopadhyay P; Yeh HW; Allred DC; Hu M; Polyak K; Rosen JM; Medina D
Breast Cancer Res; 2009; 11(5):R66. PubMed ID: 19735549
[TBL] [Abstract][Full Text] [Related]
17. Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast.
Gandhi A; Holland PA; Knox WF; Potten CS; Bundred NJ
Br J Cancer; 1998 Sep; 78(6):788-94. PubMed ID: 9743302
[TBL] [Abstract][Full Text] [Related]
18. CD8(+) tumor-infiltrating lymphocytes contribute to spontaneous "healing" in HER2-positive ductal carcinoma in situ.
Morita M; Yamaguchi R; Tanaka M; Tse GM; Yamaguchi M; Kanomata N; Naito Y; Akiba J; Hattori S; Minami S; Eguchi S; Yano H
Cancer Med; 2016 Jul; 5(7):1607-18. PubMed ID: 27061242
[TBL] [Abstract][Full Text] [Related]
19. TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells.
Yang M; Yu X; Li X; Luo B; Yang W; Lin Y; Li D; Gan Z; Xu J; He T
Breast Cancer Res; 2018 Aug; 20(1):97. PubMed ID: 30111373
[TBL] [Abstract][Full Text] [Related]
20. Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions.
Shekhar MP; Nangia-Makker P; Tait L; Miller F; Raz A
Am J Pathol; 2004 Dec; 165(6):1931-41. PubMed ID: 15579437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
